世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

バイオ製造の世界市場:製品タイプ別(抗体(MoAb)、サイトカイン、酵素、融合タンパク質、その他)、ソース別(微生物培養、植物ベース、動物ベース)、方法別(細胞培養(哺乳類vs微生物、血漿分画、その他)、装置別(プラスチックvsスチール)、タイプ別(再利用可能、使い捨て、自動、手動。自動化、手動化), 技術別 (ダウンストリーム処理、アップストリーム処理、その他), アプリケーション別 (診断、治療), エンドユーザー別 (バイオテクノロジーおよび生物薬剤企業、CMO、その他), 地域別, 競争、予測、機会, 2025年


Global Bio-Manufacturing Market By Product Type (Antibodies (MoAb), Cytokines, Enzymes, Fusion Proteins, Others), By Source (Microbial Culture, Plant-Based, Animal-Based), By Method (Cell Culture (Mammalian v/s Microbial, Blood Plasma Fractionation, Others), By Equipment (Plastic v/s Steel), By Type (Reusable, Disposable; Automated, Manual), By Technology (Down Stream Processing, Upstream Processing, Others), By Application (Diagnostics, Therapeutics), By End User (Biotechnology & Biopharmaceutical Companies, CMOs, Others), By Region, Competition, Forecast & Opportunities, 2025

世界のバイオ製造市場は、糖尿病や癌などの様々な慢性疾患の有病率の上昇を背景に、今後5年間にわたり堅調なペースで成長すると予想されています。これは、これらの疾患の効果的かつ迅速な治療に対する需要を著... もっと見る

 

 

出版社 出版年月 電子版価格 ページ数 言語
TechSci Research
テックサイリサーチ
2022年7月1日 US$4,900
シングルユーザライセンス(印刷不可)
ライセンス・価格情報
注文方法はこちら
114 英語

 

サマリー


世界のバイオ製造市場は、糖尿病や癌などの様々な慢性疾患の有病率の上昇を背景に、今後5年間にわたり堅調なペースで成長すると予想されています。これは、これらの疾患の効果的かつ迅速な治療に対する需要を著しく増大させ、ひいてはバイオ製造市場にプラスの影響を及ぼすと予想されます。さらに、生物製剤の認可の増加は、予測期間中に市場を推進することが期待されます。さらに、医薬品、ワクチン、酵素などの開発パイプラインを増やすために、さまざまな政府や主要な市場参加者による支出の増加や先進的なバイオ製造戦略の採用が、2025年までの市場成長を促進すると予測されます。しかし、製品汚染のリスクが市場成長の妨げになる可能性があります。また、GMPに関する厳しい規制の枠組みは、今後数年間の市場成長を阻害する可能性があります。

世界のバイオ製造市場は、製品タイプ、ソース、方法、装置、タイプ、技術、アプリケーション、エンドユーザー、および地域に基づいて区分されます。製品タイプに基づき、市場は抗体(MoAb)、サイトカイン、酵素、融合タンパク質、ホルモン、組み換えタンパク質、その他に細分化される可能性があります。今後5年間は、モノクローナル抗体セグメントが市場を支配すると予想されます。さらに、Humira、Remicade、Enbrel、Rituxan、Avastin、Herceptinなど、バイオ製造プロセスを用いて製造されたさまざまなモノクローナル抗体が2015年から市場に出回っており、市場で非常に好調に推移しています。また、様々なモノクローナル抗体がBLAまたは同等の段階にあり、それによってこのセグメントの成長を促進しています。技術は、下流工程、上流工程、統合型、シングルユースに分類されます。シングルユースセグメントは、汚染リスクの低減、多品種生産施設における高い柔軟性、費用対効果などの関連メリットにより、大きな成長を遂げると予想されます。エンドユーザーに基づくと、市場はバイオテクノロジーおよびバイオ医薬品企業、CMO、CRO、CDMO、その他に分類されます。CMOは、生物製剤の臨床・商業供給に対する需要の増加が見込まれるため、2025年まで市場を支配すると予想されています。

すべての地域の中で、アジア太平洋地域は、特に中国やインドといった国々で、政府およびさまざまな官民プレーヤーによる医療支出の増加により、バイオ製造市場の著しい成長が見込まれています。このため、これらの国々の多くの国内製薬会社は、モノクローナル抗体や組み換えタンパク質など、さまざまな生物学的製剤を開発することができます。さらに、市場で事業を展開する主要企業の多くは、低コストの労働力と製造施設が利用可能であることから、アジア太平洋地域で事業を拡大しており、それによって有利な機会が生み出されています。

世界のバイオ製造市場で事業を展開する主要企業には、Abbott Laboratories、Abzena Ltd.、AGC Biologics GmbH、Althea Inc.、Amgen Inc.、Asymchem Laboratories Inc.、Baxter Biopharma Solutions LLC、Biocon Ltd., Biogen Inc.、Asikon Inc.、Asikon Inc,Boehringer Ingelheim GmbH、Celgene Corporation、Danaher Corporation、Fujifilm Diosynth Biotechnologies、Gilead Sciences, Inc、Lonza Group、MicroProtein Technologies, Inc、Novo Nordisk、Patheon N.V. (Thermo Fischer Scientific) 、Proteogenix Inc、Proteus Digital Health Inc.などの企業があります。
本レポートで考慮した年数
歴史的年数:2015年~2018年
基本年:2019年
推定年:2020年
予測年:2021年~2025年
本調査の目的
- 世界のバイオ製造市場の2015年から2018年までの市場規模を分析・予測すること。
- 2019年から2025年までの世界のバイオ製造市場の市場規模を予測・推計する。
- 世界のバイオ製造市場を製品タイプ、ソース、方法、装置、タイプ、技術、用途、エンドユーザー、地域分布に基づき分類・予測する。
- 世界のバイオ製造市場における支配的な地域またはセグメントを特定する。
- 世界のバイオ製造市場の促進要因と課題を特定する。
- 世界のバイオ製造市場における拡張、新製品発表、M&Aなどの競合開発を調査する。
- 世界のバイオ製造市場で事業を展開する主要企業のプロファイルを特定し、分析する。
- 世界のバイオ製造市場で市場参入企業が採用する持続可能な主要戦略を特定する。
TechSci Researchはこの調査のために一次調査と徹底的な二次調査の両方を実施しました。まず、TechSci Researchは世界中で活動する市場プレイヤーのリストを入手しました。その後、TechSci Researchは特定された企業に対して一次調査を実施しました。インタビューしながら、回答者には競合他社についても質問しました。この手法により、TechSci Researchは、二次調査の制限により特定できなかった企業も含めることができました。TechSci Research は、世界中のすべての主要企業のメーカー、流通チャネル、存在を分析しました。
TechSci Researchは、様々なエンドユーザーセグメントのデータを記録し、将来的な予測を行うボトムアップアプローチを用いて、世界のバイオ製造市場の市場規模を算出した。TechSci Researchは、これらの値を業界の専門家や企業の代表者から入手し、適切で全体的な市場規模を得るためにこれらの製品タイプやアプリケーションの履歴データを分析することで外部的に検証しました。企業のウェブサイト、ニュース記事、プレスリリース、企業の年次報告書、投資家向けプレゼンテーション、財務報告書など、さまざまな二次資料もTechSci Researchによって調査されました。
主な対象読者
- バイオ製造企業およびその他の関係者
- 規制当局や政策立案者などの政府機関
- バイオ製造に関連する組織、フォーラム、アライアンス
- 市場調査会社およびコンサルティング会社
本調査は、メーカー、サプライヤー、パートナーなどの業界関係者にとって重要ないくつかの重要な質問に対する回答を提供し、さらに、投資の戦略立案や市場機会の活用を可能にするものである。
レポートの範囲
本レポートでは、バイオ製造の世界市場を、以下に詳述する業界動向に加えて、以下のカテゴリーに分類しています。
- 製品タイプ別
o 抗体 (MoAb)
o サイトカイン
o 酵素
o 融合タンパク質
o ホルモン
o リコンビナントタンパク質
o その他
- 供給元別
o 微生物培養
o 植物由来
o 動物由来
- 方法別
o 細胞培養
哺乳類
微生物
o 血漿分画
o カラムクロマトグラフィー
ホモジナイズ
その他
- 装置別
o プラスチック
o スチール
- タイプ別
o 再使用可能
o 使い捨て
o 自動化
o マニュアル
- 技術別
o 下流工程
o アップストリームプロセッシング
o 統合
o シングルユース
- アプリケーション別
o 診断薬
o 治療薬
- エンドユーザー別
o バイオテクノロジー&バイオ製薬会社
o CMO
o CRO
o CDMO
o その他
- 地域別
o 北米
米国
カナダ
メキシコ
o 欧州
ドイツ
フランス
イギリス
イタリア
スペイン
o アジア太平洋地域
中国
日本
インド
韓国
オーストラリア
o 中東・アフリカ
南アフリカ共和国
サウジアラビア
UAE
クウェート
o 南米
ブラジル
アルゼンチン
コロンビア
競合他社の状況
企業プロファイル。世界のバイオ製造市場に存在する主要企業の詳細分析
利用可能なカスタマイズ。
TechSci Researchでは、与えられた市場データをもとに、企業の特定のニーズに応じたカスタマイズを提供しています。本レポートでは、以下のカスタマイズが可能です。
企業情報
- 追加的な市場プレイヤーの詳細分析とプロファイリング(最大5社まで)。

ページTOPに戻る


目次

1. Product Overview
2. Research Methodology
3. Impact of COVID-19 on Global Bio-Manufacturing Market
4. Executive Summary
5. Voice of Customer
6. Global Bio-Manufacturing Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Product Type (Antibodies (MoAb), Cytokines, Enzymes, Fusion Proteins, Hormones, Recombinant Proteins, Others)
6.2.2. By Source (Microbial Culture, Plant-Based, Animal-Based)
6.2.3. By Method (Cell Culture (Mammalian v/s Microbial), Blood Plasma Fractionation, Column Chromatography, Homogenization, Others)
6.2.4. By Equipment (Plastic v/s Steel)
6.2.5. By Type (Reusable, Disposable, Automated, Manual)
6.2.6. By Technology (Downstream Processing, Upstream Processing, Integrated, Single Use)
6.2.7. By Application (Diagnostics v/s Therapeutics)
6.2.8. By End User (Biotechnology & Biopharmaceutical Companies, CMOs, CROs, CDMOs, Others)
6.2.9. By Company (2019)
6.2.10. By Region
6.3. Product Market Map
7. Asia-Pacific Bio-Manufacturing Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Product Type
7.2.2. By Source
7.2.3. By Method
7.2.4. By Equipment
7.2.5. By Type
7.2.6. By Technology
7.2.7. By Application
7.2.8. By End User
7.2.9. By Country
7.3. Asia-Pacific: Country Analysis
7.3.1. China Bio-Manufacturing Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Product Type
7.3.1.2.2. By Source
7.3.1.2.3. By Method
7.3.1.2.4. By Equipment
7.3.1.2.5. By Type
7.3.1.2.6. By Technology
7.3.1.2.7. By Application
7.3.1.2.8. By End User
7.3.2. India Bio-Manufacturing Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Product Type
7.3.2.2.2. By Source
7.3.2.2.3. By Method
7.3.2.2.4. By Equipment
7.3.2.2.5. By Type
7.3.2.2.6. By Technology
7.3.2.2.7. By Application
7.3.2.2.8. By End User
7.3.3. Australia Bio-Manufacturing Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Product Type
7.3.3.2.2. By Source
7.3.3.2.3. By Method
7.3.3.2.4. By Equipment
7.3.3.2.5. By Type
7.3.3.2.6. By Technology
7.3.3.2.7. By Application
7.3.3.2.8. By End User
7.3.4. Japan Bio-Manufacturing Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Product Type
7.3.4.2.2. By Source
7.3.4.2.3. By Method
7.3.4.2.4. By Equipment
7.3.4.2.5. By Type
7.3.4.2.6. By Technology
7.3.4.2.7. By Application
7.3.4.2.8. By End User
7.3.5. South Korea Bio-Manufacturing Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Product Type
7.3.5.2.2. By Source
7.3.5.2.3. By Method
7.3.5.2.4. By Equipment
7.3.5.2.5. By Type
7.3.5.2.6. By Technology
7.3.5.2.7. By Application
7.3.5.2.8. By End User
8. Europe Bio-Manufacturing Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Product Type
8.2.2. By Source
8.2.3. By Method
8.2.4. By Equipment
8.2.5. By Type
8.2.6. By Technology
8.2.7. By Application
8.2.8. By End User
8.2.9. By Country
8.3. Europe: Country Analysis
8.3.1. France Bio-Manufacturing Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Product Type
8.3.1.2.2. By Source
8.3.1.2.3. By Method
8.3.1.2.4. By Equipment
8.3.1.2.5. By Type
8.3.1.2.6. By Technology
8.3.1.2.7. By Application
8.3.1.2.8. By End User
8.3.2. Germany Bio-Manufacturing Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Product Type
8.3.2.2.2. By Source
8.3.2.2.3. By Method
8.3.2.2.4. By Equipment
8.3.2.2.5. By Type
8.3.2.2.6. By Technology
8.3.2.2.7. By Application
8.3.2.2.8. By End User
8.3.3. United Kingdom Bio-Manufacturing Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Product Type
8.3.3.2.2. By Source
8.3.3.2.3. By Method
8.3.3.2.4. By Equipment
8.3.3.2.5. By Type
8.3.3.2.6. By Technology
8.3.3.2.7. By Application
8.3.3.2.8. By End User
8.3.4. Italy Bio-Manufacturing Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Product Type
8.3.4.2.2. By Source
8.3.4.2.3. By Method
8.3.4.2.4. By Equipment
8.3.4.2.5. By Type
8.3.4.2.6. By Technology
8.3.4.2.7. By Application
8.3.4.2.8. By End User
8.3.5. Spain Bio-Manufacturing Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Product Type
8.3.5.2.2. By Source
8.3.5.2.3. By Method
8.3.5.2.4. By Equipment
8.3.5.2.5. By Type
8.3.5.2.6. By Technology
8.3.5.2.7. By Application
8.3.5.2.8. By End User
9. North America Bio-Manufacturing Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Product Type
9.2.2. By Source
9.2.3. By Method
9.2.4. By Equipment
9.2.5. By Type
9.2.6. By Technology
9.2.7. By Application
9.2.8. By End User
9.2.9. By Country
9.3. North America: Country Analysis
9.3.1. United States Bio-Manufacturing Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Product Type
9.3.1.2.2. By Source
9.3.1.2.3. By Method
9.3.1.2.4. By Equipment
9.3.1.2.5. By Type
9.3.1.2.6. By Technology
9.3.1.2.7. By Application
9.3.1.2.8. By End User
9.3.2. Mexico Bio-Manufacturing Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Product Type
9.3.2.2.2. By Source
9.3.2.2.3. By Method
9.3.2.2.4. By Equipment
9.3.2.2.5. By Type
9.3.2.2.6. By Technology
9.3.2.2.7. By Application
9.3.2.2.8. By End User
9.3.3. Canada Bio-Manufacturing Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Product Type
9.3.3.2.2. By Source
9.3.3.2.3. By Method
9.3.3.2.4. By Equipment
9.3.3.2.5. By Type
9.3.3.2.6. By Technology
9.3.3.2.7. By Application
9.3.3.2.8. By End User
10. South America Bio-Manufacturing Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Product Type
10.2.2. By Source
10.2.3. By Method
10.2.4. By Equipment
10.2.5. By Type
10.2.6. By Technology
10.2.7. By Application
10.2.8. By End User
10.2.9. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Bio-Manufacturing Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Product Type
10.3.1.2.2. By Source
10.3.1.2.3. By Method
10.3.1.2.4. By Equipment
10.3.1.2.5. By Type
10.3.1.2.6. By Technology
10.3.1.2.7. By Application
10.3.1.2.8. By End User
10.3.2. Argentina Bio-Manufacturing Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Product Type
10.3.2.2.2. By Source
10.3.2.2.3. By Method
10.3.2.2.4. By Equipment
10.3.2.2.5. By Type
10.3.2.2.6. By Technology
10.3.2.2.7. By Application
10.3.2.2.8. By End User
10.3.3. Colombia Bio-Manufacturing Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Product Type
10.3.3.2.2. By Source
10.3.3.2.3. By Method
10.3.3.2.4. By Equipment
10.3.3.2.5. By Type
10.3.3.2.6. By Technology
10.3.3.2.7. By Application
10.3.3.2.8. By End User
11. Middle East and Africa Bio-Manufacturing Market Outlook
11.1. Market Size & Forecast
11.1.1. By Value
11.2. Market Share & Forecast
11.2.1. By Product Type
11.2.2. By Source
11.2.3. By Method
11.2.4. By Equipment
11.2.5. By Type
11.2.6. By Technology
11.2.7. By Application
11.2.8. By End User
11.2.9. By Country
11.3. MEA: Country Analysis
11.3.1. South Africa Bio-Manufacturing Market Outlook
11.3.1.1. Market Size & Forecast
11.3.1.1.1. By Value
11.3.1.2. Market Share & Forecast
11.3.1.2.1. By Product Type
11.3.1.2.2. By Source
11.3.1.2.3. By Method
11.3.1.2.4. By Equipment
11.3.1.2.5. By Type
11.3.1.2.6. By Technology
11.3.1.2.7. By Application
11.3.1.2.8. By End User
11.3.2. Saudi Arabia Bio-Manufacturing Market Outlook
11.3.2.1. Market Size & Forecast
11.3.2.1.1. By Value
11.3.2.2. Market Share & Forecast
11.3.2.2.1. By Product Type
11.3.2.2.2. By Source
11.3.2.2.3. By Method
11.3.2.2.4. By Equipment
11.3.2.2.5. By Type
11.3.2.2.6. By Technology
11.3.2.2.7. By Application
11.3.2.2.8. By End User
11.3.3. UAE Bio-Manufacturing Market Outlook
11.3.3.1. Market Size & Forecast
11.3.3.1.1. By Value
11.3.3.2. Market Share & Forecast
11.3.3.2.1. By Product Type
11.3.3.2.2. By Source
11.3.3.2.3. By Method
11.3.3.2.4. By Equipment
11.3.3.2.5. By Type
11.3.3.2.6. By Technology
11.3.3.2.7. By Application
11.3.3.2.8. By End User
11.3.4. Kuwait Bio-Manufacturing Market Outlook
11.3.4.1. Market Size & Forecast
11.3.4.1.1. By Value
11.3.4.2. Market Share & Forecast
11.3.4.2.1. By Product Type
11.3.4.2.2. By Source
11.3.4.2.3. By Method
11.3.4.2.4. By Equipment
11.3.4.2.5. By Type
11.3.4.2.6. By Technology
11.3.4.2.7. By Application
11.3.4.2.8. By End User
12. Market Dynamics
12.1. Drivers
12.2. Challenges
13. Market Trends & Developments
13.1. Cell Line Engineering
13.2. Disposable Manufacturing Technology
13.3. Perfusion Culture
13.4. In-Silico Modelling
13.5. Modular Factories
14. Patent Analysis
15. Competitive Landscape
15.1. Competition Outlook
15.2. Company Profiles
15.3. Company Details
15.4. Financials (As Reported)
15.5. Supply/ Value Chain Analysis
15.6. SWOT Analysis
15.7. Key Market Focus and Geographical Presence
15.8. Planned Investments
15.9. Market Positioning
15.10. Import Export Analysis (By Region)
15.11. Pricing Analysis (By Country)
15.12. Leading Players Profiled
15.12.1. Abbott Laboratories
15.12.2. Abzena Ltd.
15.12.3. AGC Biologics GmbH
15.12.4. Althea Inc.
15.12.5. Amgen Inc.
15.12.6. Asymchem Laboratories Inc.
15.12.7. Baxter Biopharma Solutions LLC
15.12.8. Biocon Ltd.
15.12.9. Biogen Inc.
15.12.10. Boehringer Ingelheim GmbH
15.12.11. Celgene Corporation
15.12.12. Danaher Corporation
15.12.13. Fujifilm Diosynth Biotechnologies
15.12.14. Gilead Sciences, Inc
15.12.15. Lonza Group
15.12.16. MicroProtein Technologies, Inc.
15.12.17. Novo Nordisk
15.12.18. Patheon N.V. (Thermo Fischer Scientific)
15.12.19. Proteogenix Inc.
15.12.20. Proteus Digital Health Inc.
16. Strategic Recommendations

 

ページTOPに戻る


 

Summary


Global bio-manufacturing market is expected to grow at a robust pace over the next five years, driven by the rising prevalence of various chronic diseases such as diabetes, cancer, among others. This has been significantly augmenting the demand for effective and faster treatment of these diseases, which in turn is expected to positively influence the bio-manufacturing market. Additionally, increase in the approvals of biologics is further expected to propel the market during forecast period. Furthermore, increasing expenditure by various governments and major market players and adoption of advanced biomanufacturing strategies to increase the development pipeline of drugs, vaccines, enzymes, among others is expected to foster the market growth through 2025. However, the associated risk of product contamination can hamper the market growth. Also, strict regulatory framework regarding GMP can impede the market growth over next few years.

The global bio-manufacturing market is segmented based on product type, source, method, equipment, type, technology, application, end user, and region. Based on product type, the market can be fragmented into antibodies (MoAb), cytokines, enzymes, fusion proteins, hormones, recombinant proteins and others. The monoclonal antibodies segment is expected to dominate the market over the next five years. Additionally, various monoclonal antibodies such as Humira, Remicade, Enbrel, Rituxan, Avastin and Herceptin are available in the market since 2015 which were manufactured using bio-manufacturing process and are doing very well in the market. Also, various monoclonal antibodies are in BLA or equivalent stages thereby driving the growth of segment. Based on technology, the market can be categorized into downstream processing, upstream processing, integrated and single use. The single use segment is expected to witness significant growth on account of the associated benefits such as reduced risk of contamination, higher flexibility in multiproduct facilities, cost-effectiveness, among others. Based on end user, the market can be segmented into biotechnology & biopharmaceutical companies, CMOs, CROs, CDMOs and others. The CMOs are expected to dominate the market through 2025 due to anticipated increase in demand for clinical and commercial supply of biologics.

Among all the regions, Asia Pacific is expected to witness significant growth in its bio-manufacturing market owing to the increasing healthcare expenditure by the government and various public-private players, especially in countries like China and India. This has allowed a lot of domestic pharmaceutical companies in these countries to develop a range of biologic products such as monoclonal antibodies, recombinant proteins, among others. Additionally, most of the major players operating in the market are expanding in Asia Pacific due to availability of low cost labor as well as manufacturing facilities, thereby creating lucrative opportunities.

Major players operating in the global bio-manufacturing market include Abbott Laboratories, Abzena Ltd., AGC Biologics GmbH, Althea Inc., Amgen Inc., Asymchem Laboratories Inc., Baxter Biopharma Solutions LLC, Biocon Ltd., Biogen Inc., Boehringer Ingelheim GmbH, Celgene Corporation, Danaher Corporation, Fujifilm Diosynth Biotechnologies, Gilead Sciences, Inc, Lonza Group, MicroProtein Technologies, Inc., Novo Nordisk, Patheon N.V. (Thermo Fischer Scientific), Proteogenix Inc., Proteus Digital Health Inc., among others.
Years considered for this report:
Historical Years: 2015-2018
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2021–2025
Objective of the Study:
• To analyze and estimate the market size of global bio-manufacturing market from 2015 to 2018.
• To estimate and forecast the market size of global bio-manufacturing market from 2019 to 2025.
• To classify and forecast global bio-manufacturing market based on product type, source, method, equipment, type, technology, application, end user, and regional distribution.
• To identify dominant region or segment in the global bio-manufacturing market.
• To identify drivers and challenges for global bio-manufacturing market.
• To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in the global bio-manufacturing market.
• To identify and analyze the profile of leading players operating in global bio-manufacturing market.
• To identify key sustainable strategies adopted by market players in global bio-manufacturing market.
TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of market players operating across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the companies which could not be identified due to the limitations of secondary research. TechSci Research analyzed the manufacturers, distribution channels and presence of all major players across the globe.
TechSci Research calculated the market size of global bio-manufacturing market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.
Key Target Audience:
• Bio-manufacturing companies and other stakeholders
• Government bodies such as regulating authorities and policy makers
• Organizations, forums and alliances related to bio-manufacturing
• Market research and consulting firms
The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers, suppliers and partners, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.
Report Scope:
In this report, global bio-manufacturing market has been segmented into following categories, in addition to the industry trends which have also been detailed below:
• By Product Type:
o Antibodies (MoAb)
o Cytokines
o Enzymes
o Fusion Proteins
o Hormones
o Recombinant Proteins
o Others
• By Source:
o Microbial Culture
o Plant-Based
o Animal-Based
• By Method:
o Cell Culture
 Mammalian
 Microbial
o Blood Plasma Fractionation
o Column Chromatography
o Homogenization
o Others
• By Equipment:
o Plastic
o Steel
• By Type:
o Reusable
o Disposable
o Automated
o Manual
• By Technology:
o Downstream Processing
o Upstream Processing
o Integrated
o Single Use
• By Application:
o Diagnostics
o Therapeutics
• By End User:
o Biotechnology & Biopharmaceutical Companies
o CMOs
o CROs
o CDMOs
o Others
• By Region:
o North America
 United States
 Canada
 Mexico
o Europe
 Germany
 France
 United Kingdom
 Italy
 Spain
o Asia-Pacific
 China
 Japan
 India
 South Korea
 Australia
o Middle East & Africa
 South Africa
 Saudi Arabia
 UAE
 Kuwait
o South America
 Brazil
 Argentina
 Colombia
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in global bio-manufacturing market.
Available Customizations:
With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:
Company Information
• Detailed analysis and profiling of additional market players (up to five).



ページTOPに戻る


Table of Contents

1. Product Overview
2. Research Methodology
3. Impact of COVID-19 on Global Bio-Manufacturing Market
4. Executive Summary
5. Voice of Customer
6. Global Bio-Manufacturing Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Product Type (Antibodies (MoAb), Cytokines, Enzymes, Fusion Proteins, Hormones, Recombinant Proteins, Others)
6.2.2. By Source (Microbial Culture, Plant-Based, Animal-Based)
6.2.3. By Method (Cell Culture (Mammalian v/s Microbial), Blood Plasma Fractionation, Column Chromatography, Homogenization, Others)
6.2.4. By Equipment (Plastic v/s Steel)
6.2.5. By Type (Reusable, Disposable, Automated, Manual)
6.2.6. By Technology (Downstream Processing, Upstream Processing, Integrated, Single Use)
6.2.7. By Application (Diagnostics v/s Therapeutics)
6.2.8. By End User (Biotechnology & Biopharmaceutical Companies, CMOs, CROs, CDMOs, Others)
6.2.9. By Company (2019)
6.2.10. By Region
6.3. Product Market Map
7. Asia-Pacific Bio-Manufacturing Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Product Type
7.2.2. By Source
7.2.3. By Method
7.2.4. By Equipment
7.2.5. By Type
7.2.6. By Technology
7.2.7. By Application
7.2.8. By End User
7.2.9. By Country
7.3. Asia-Pacific: Country Analysis
7.3.1. China Bio-Manufacturing Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Product Type
7.3.1.2.2. By Source
7.3.1.2.3. By Method
7.3.1.2.4. By Equipment
7.3.1.2.5. By Type
7.3.1.2.6. By Technology
7.3.1.2.7. By Application
7.3.1.2.8. By End User
7.3.2. India Bio-Manufacturing Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Product Type
7.3.2.2.2. By Source
7.3.2.2.3. By Method
7.3.2.2.4. By Equipment
7.3.2.2.5. By Type
7.3.2.2.6. By Technology
7.3.2.2.7. By Application
7.3.2.2.8. By End User
7.3.3. Australia Bio-Manufacturing Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Product Type
7.3.3.2.2. By Source
7.3.3.2.3. By Method
7.3.3.2.4. By Equipment
7.3.3.2.5. By Type
7.3.3.2.6. By Technology
7.3.3.2.7. By Application
7.3.3.2.8. By End User
7.3.4. Japan Bio-Manufacturing Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Product Type
7.3.4.2.2. By Source
7.3.4.2.3. By Method
7.3.4.2.4. By Equipment
7.3.4.2.5. By Type
7.3.4.2.6. By Technology
7.3.4.2.7. By Application
7.3.4.2.8. By End User
7.3.5. South Korea Bio-Manufacturing Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Product Type
7.3.5.2.2. By Source
7.3.5.2.3. By Method
7.3.5.2.4. By Equipment
7.3.5.2.5. By Type
7.3.5.2.6. By Technology
7.3.5.2.7. By Application
7.3.5.2.8. By End User
8. Europe Bio-Manufacturing Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Product Type
8.2.2. By Source
8.2.3. By Method
8.2.4. By Equipment
8.2.5. By Type
8.2.6. By Technology
8.2.7. By Application
8.2.8. By End User
8.2.9. By Country
8.3. Europe: Country Analysis
8.3.1. France Bio-Manufacturing Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Product Type
8.3.1.2.2. By Source
8.3.1.2.3. By Method
8.3.1.2.4. By Equipment
8.3.1.2.5. By Type
8.3.1.2.6. By Technology
8.3.1.2.7. By Application
8.3.1.2.8. By End User
8.3.2. Germany Bio-Manufacturing Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Product Type
8.3.2.2.2. By Source
8.3.2.2.3. By Method
8.3.2.2.4. By Equipment
8.3.2.2.5. By Type
8.3.2.2.6. By Technology
8.3.2.2.7. By Application
8.3.2.2.8. By End User
8.3.3. United Kingdom Bio-Manufacturing Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Product Type
8.3.3.2.2. By Source
8.3.3.2.3. By Method
8.3.3.2.4. By Equipment
8.3.3.2.5. By Type
8.3.3.2.6. By Technology
8.3.3.2.7. By Application
8.3.3.2.8. By End User
8.3.4. Italy Bio-Manufacturing Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Product Type
8.3.4.2.2. By Source
8.3.4.2.3. By Method
8.3.4.2.4. By Equipment
8.3.4.2.5. By Type
8.3.4.2.6. By Technology
8.3.4.2.7. By Application
8.3.4.2.8. By End User
8.3.5. Spain Bio-Manufacturing Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Product Type
8.3.5.2.2. By Source
8.3.5.2.3. By Method
8.3.5.2.4. By Equipment
8.3.5.2.5. By Type
8.3.5.2.6. By Technology
8.3.5.2.7. By Application
8.3.5.2.8. By End User
9. North America Bio-Manufacturing Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Product Type
9.2.2. By Source
9.2.3. By Method
9.2.4. By Equipment
9.2.5. By Type
9.2.6. By Technology
9.2.7. By Application
9.2.8. By End User
9.2.9. By Country
9.3. North America: Country Analysis
9.3.1. United States Bio-Manufacturing Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Product Type
9.3.1.2.2. By Source
9.3.1.2.3. By Method
9.3.1.2.4. By Equipment
9.3.1.2.5. By Type
9.3.1.2.6. By Technology
9.3.1.2.7. By Application
9.3.1.2.8. By End User
9.3.2. Mexico Bio-Manufacturing Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Product Type
9.3.2.2.2. By Source
9.3.2.2.3. By Method
9.3.2.2.4. By Equipment
9.3.2.2.5. By Type
9.3.2.2.6. By Technology
9.3.2.2.7. By Application
9.3.2.2.8. By End User
9.3.3. Canada Bio-Manufacturing Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Product Type
9.3.3.2.2. By Source
9.3.3.2.3. By Method
9.3.3.2.4. By Equipment
9.3.3.2.5. By Type
9.3.3.2.6. By Technology
9.3.3.2.7. By Application
9.3.3.2.8. By End User
10. South America Bio-Manufacturing Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Product Type
10.2.2. By Source
10.2.3. By Method
10.2.4. By Equipment
10.2.5. By Type
10.2.6. By Technology
10.2.7. By Application
10.2.8. By End User
10.2.9. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Bio-Manufacturing Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Product Type
10.3.1.2.2. By Source
10.3.1.2.3. By Method
10.3.1.2.4. By Equipment
10.3.1.2.5. By Type
10.3.1.2.6. By Technology
10.3.1.2.7. By Application
10.3.1.2.8. By End User
10.3.2. Argentina Bio-Manufacturing Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Product Type
10.3.2.2.2. By Source
10.3.2.2.3. By Method
10.3.2.2.4. By Equipment
10.3.2.2.5. By Type
10.3.2.2.6. By Technology
10.3.2.2.7. By Application
10.3.2.2.8. By End User
10.3.3. Colombia Bio-Manufacturing Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Product Type
10.3.3.2.2. By Source
10.3.3.2.3. By Method
10.3.3.2.4. By Equipment
10.3.3.2.5. By Type
10.3.3.2.6. By Technology
10.3.3.2.7. By Application
10.3.3.2.8. By End User
11. Middle East and Africa Bio-Manufacturing Market Outlook
11.1. Market Size & Forecast
11.1.1. By Value
11.2. Market Share & Forecast
11.2.1. By Product Type
11.2.2. By Source
11.2.3. By Method
11.2.4. By Equipment
11.2.5. By Type
11.2.6. By Technology
11.2.7. By Application
11.2.8. By End User
11.2.9. By Country
11.3. MEA: Country Analysis
11.3.1. South Africa Bio-Manufacturing Market Outlook
11.3.1.1. Market Size & Forecast
11.3.1.1.1. By Value
11.3.1.2. Market Share & Forecast
11.3.1.2.1. By Product Type
11.3.1.2.2. By Source
11.3.1.2.3. By Method
11.3.1.2.4. By Equipment
11.3.1.2.5. By Type
11.3.1.2.6. By Technology
11.3.1.2.7. By Application
11.3.1.2.8. By End User
11.3.2. Saudi Arabia Bio-Manufacturing Market Outlook
11.3.2.1. Market Size & Forecast
11.3.2.1.1. By Value
11.3.2.2. Market Share & Forecast
11.3.2.2.1. By Product Type
11.3.2.2.2. By Source
11.3.2.2.3. By Method
11.3.2.2.4. By Equipment
11.3.2.2.5. By Type
11.3.2.2.6. By Technology
11.3.2.2.7. By Application
11.3.2.2.8. By End User
11.3.3. UAE Bio-Manufacturing Market Outlook
11.3.3.1. Market Size & Forecast
11.3.3.1.1. By Value
11.3.3.2. Market Share & Forecast
11.3.3.2.1. By Product Type
11.3.3.2.2. By Source
11.3.3.2.3. By Method
11.3.3.2.4. By Equipment
11.3.3.2.5. By Type
11.3.3.2.6. By Technology
11.3.3.2.7. By Application
11.3.3.2.8. By End User
11.3.4. Kuwait Bio-Manufacturing Market Outlook
11.3.4.1. Market Size & Forecast
11.3.4.1.1. By Value
11.3.4.2. Market Share & Forecast
11.3.4.2.1. By Product Type
11.3.4.2.2. By Source
11.3.4.2.3. By Method
11.3.4.2.4. By Equipment
11.3.4.2.5. By Type
11.3.4.2.6. By Technology
11.3.4.2.7. By Application
11.3.4.2.8. By End User
12. Market Dynamics
12.1. Drivers
12.2. Challenges
13. Market Trends & Developments
13.1. Cell Line Engineering
13.2. Disposable Manufacturing Technology
13.3. Perfusion Culture
13.4. In-Silico Modelling
13.5. Modular Factories
14. Patent Analysis
15. Competitive Landscape
15.1. Competition Outlook
15.2. Company Profiles
15.3. Company Details
15.4. Financials (As Reported)
15.5. Supply/ Value Chain Analysis
15.6. SWOT Analysis
15.7. Key Market Focus and Geographical Presence
15.8. Planned Investments
15.9. Market Positioning
15.10. Import Export Analysis (By Region)
15.11. Pricing Analysis (By Country)
15.12. Leading Players Profiled
15.12.1. Abbott Laboratories
15.12.2. Abzena Ltd.
15.12.3. AGC Biologics GmbH
15.12.4. Althea Inc.
15.12.5. Amgen Inc.
15.12.6. Asymchem Laboratories Inc.
15.12.7. Baxter Biopharma Solutions LLC
15.12.8. Biocon Ltd.
15.12.9. Biogen Inc.
15.12.10. Boehringer Ingelheim GmbH
15.12.11. Celgene Corporation
15.12.12. Danaher Corporation
15.12.13. Fujifilm Diosynth Biotechnologies
15.12.14. Gilead Sciences, Inc
15.12.15. Lonza Group
15.12.16. MicroProtein Technologies, Inc.
15.12.17. Novo Nordisk
15.12.18. Patheon N.V. (Thermo Fischer Scientific)
15.12.19. Proteogenix Inc.
15.12.20. Proteus Digital Health Inc.
16. Strategic Recommendations

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野(バイオマス)の最新刊レポート

TechSci Research社のバイオマス分野での最新刊レポート


よくあるご質問


TechSci Research社はどのような調査会社ですか?


テックサイリサーチ(TechSci Research)は、カナダ、英国、インドに拠点を持ち、化学、IT、環境、消費財と小売、自動車、エネルギーと発電の市場など、多様な産業や地域を対象とした調査・出版活... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/12/24 10:26

158.45 円

165.22 円

201.28 円

ページTOPに戻る